Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Schulman, Sam; Kearon, Clive; K. Kakkar, Ajay; Schellong, Sebastian; Eriksson, Henry; Baanstra, David; Mathilde Kvamme, Anne; Friedman, Jeffrey; Mismetti, Patrick; Z. Goldhaber, Samuel

doi:10.1056/nejmoa1113697

Public

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Published in New England Journal of Medicine • Feb 20, 2013

Authors:

Sam Schulman

Clive Kearon

Ajay K. Kakkar

Abstract

BACKGROUND: Dabigatran, which is administered in a fixed dose and does not require laboratory monitoring, may be suitable for extended treatment of venous thromboembolism. METHODS: In two double-blind, randomized trials, we compared dabigatran at a dose of 150 mg twice daily with warfarin (active-co...

Subject

Dabigatran

Warfarin

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!